Eradication of bacteria in suspension and biofilms using methylene blue-loaded dynamic nanoplatforms

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 7, 2009, Pages 3042-3048

  Wu, Jianfeng ^a   Xu, Hao ^a   Tang, Wei ^a   Kopelman, Raoul ^a   Philbert, Martin A ^a   Xi, Chuanwu ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLASS; METHYLENE BLUE; NANOMATERIAL; NANOPARTICLE; POLYACRYLAMIDE; POLYSTYRENE;

ACINETOBACTER; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BIOFILM; DISINFECTION; ERADICATION THERAPY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HYDROGEL; LASER; NONHUMAN; PHOTOSENSITIZATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SUSPENSION;

ACINETOBACTER; ACRYLIC RESINS; ANTI-BACTERIAL AGENTS; BACTERIA; BIOFILMS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; METHYLENE BLUE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 67649991196     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01604-08     Document Type: Article

References (52)

1. Allesen-Holm, M., K. B. Barken, L. Yang, M. Klausen, J. S. Webb, S. Kjelleberg, S. Molin, M. Givskov, and T. Tolker-Nielsen. 2006. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol. Microbiol. 59:1114-1128.
2. Bonnett, R. 1995. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem. Soc. Rev. 24:19-33.
3. Cassell, G. H., and J. Mekalanos. 2001. Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance. JAMA 285:601-605.
4. Costerton, J. W., Z. Lewandowski, D. E. Caldwell, D. R. Korber, and H. M. Lappin-Scott. 1995. Microbial biofilms. Annu. Rev. Microbiol. 49:711-745.
5. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
6. Davies, D. G., and G. G. Geesey. 1995. Regulation of the alginate biosynthesis gene algC in Pseudomonas aeruginosa during biofilm development in continuous culture. Appl. Environ. Microbiol. 61:860-867.
7. de Bentzmann, S., M. Aurouze, G. Ball, and A. Filloux. 2006. FppA, a novel Pseudomonas aeruginosa prepilin peptidase involved in assembly of type IVb pili. J. Bacteriol. 188:4851-4860.
8. Demidova, T. N., and M. R. Hamblin. 2005. Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob. Agents Chemother. 49:2329-2335.
9. Derosa, M. C., and R. J. Crutchley. 2002. Photosensitized singlet oxygen and its applications. Coord. Chem. Rev. 233-234:351-371.
10. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng. 1998. Photodynamic therapy. J. Natl. Cancer Inst. 90:889-905.
11. Gabrielli, D., E. Belisle, D. Severino, A. J. Kowaltowski, and M. S. Baptista. 2004. Binding, aggregation, and photochemical properties of methylene blue in mitochondrial suspensions. Photochem. Photobiol. 79:227-232.
12. Giltner, C. L., E. J. van Schaik, G. F. Audette, D. Kao, R. S. Hodges, D. J. Hassett, and R. T. Irvin. 2006. The Pseudomonas aeruginosa type IV pilin receptor binding domain functions as an adhesin for both biotic and abiotic surfaces. Mol. Microbiol. 59:1083-1096.
13. Hall-Stoodley, L., J. W. Costerton, and P. Stoodley. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2:95-108.
14. Hamblin, M. R., and T. Hasan. 2004. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 3:436-450.
15. Hamblin, M. R., D. A. O'Donnell, N. Murthy, C. H. Contag, and T. Hasan. 2002. Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem. Photobiol. 75:51-57.
16. Hamblin, M. R., T. Zahra, C. H. Contag, A. T. McManus, and T. Hasan. 2003. Optical monitoring and treatment of potentially lethal wound infections in vivo. J. Infect. Dis. 187:1717-1725.
17. Hinman, A. R. 1998. Global progress in infectious disease control. Vaccine 16:1116-1121.
18. Hunter, R. C., and T. J. Beveridge. 2005. Application of a pH-sensitive fluoroprobe (C-SNARF-4) for pH microenvironment analysis in Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 71:2501-2510.
19. Jenkins, A. T., A. Buckling, M. McGhee, and R. H. ffrench-Constant. 2005. Surface plasmon resonance shows that type IV pili are important in surface attachment by Pseudomonas aeruginosa. J. R. Soc. Interface 2:255-259.
20. Karrer, S., C. Abels, M. B. Wimmershoff, M. Landthaler, and R. M. Szeimies. 2002. Successful treatment of cutaneous sarcoidosis using topical photodynamic therapy. Arch. Dermatol. 138:581-584.
21. Komerik, N., M. Wilson, and S. Poole. 2000. The effect of photodynamic action on two virulence factors of gram-negative bacteria. Photochem. Photobiol. 72:676-680.
22. Konan, Y. N., R. Gurny, and E. Allemann. 2002. State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B 66:89-106.
23. Koo, Y. E., G. R. Reddy, M. Bhojani, R. Schneider, M. A. Philbert, A. Rehemtulla, B. D. Ross, and R. Kopelman. 2006. Brain cancer diagnosis and therapy with nanoplatforms. Adv. Drug Deliv. Rev. 58:1556-1577.
24. Lambrechts, S. A., T. N. Demidova, M. C. Aalders, T. Hasan, and M. R. Hamblin. 2005. Photodynamic therapy for Staphylococcus aureus-infected burn wounds in mice. Photochem. Photobiol. Sci. 4:503-509.
25. Lombard, G. F., S. Tealdi, and M. M. Lanotte. 1985. The treatment of neurosurgical infections by lasers and porphyrins, p. 363-366. In G. Jori and C. A. Perria (ed.), Photodynamic therapy of tumors and other disease. Edizione Libreria Progetto, Padua, Italy.
26. Mellish, K. J., R. D. Cox, D. I. Vernon, J. Griffiths, and S. B. Brown. 2002. In vitro photodynamic activity of a series of methylene blue analogues. Photochem. Photobiol. 75:392-397.
27. 3 incorporated in polyacrylamide PEBBLES. Sens. Actuators B Chem. 90:82-89.
28. Orth, K., G. Beck, F. Genze, and A. Ruck. 2000. Methylene blue mediated photodynamic therapy in experimental colorectal tumors in mice. J. Photochem. Photobiol. B 57:186-192.
29. O'Toole, G., H. B. Kaplan, and R. Kolter. 2000. Biofilm formation as microbial development. Annu. Rev. Microbiol. 54:49-79.
30. O'Toole, G. A., and R. Kolter. 1998. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28:449-461.
31. Reddy, G. R., M. S. Bhojani, P. McConville, J. Moody, B. A. Moffat, D. E. Hall, G. Kim, Y. E. Koo, M. J. Woolliscroft, J. V. Sugai, T. D. Johnson, M. A. Philbert, R. Kopelman, A. Rehemtulla, and B. D. Ross. 2006. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin. Cancer Res. 12:6677-6686.
32. Redmond, R. W., and J. N. Gamlin. 1999. A compilation of singlet oxygen yields from biologically relevant molecules. Photochem. Photobiol. 70:391-475.
33. Roome, A. P., A. E. Tinkler, A. L. Hilton, D. G. Montefiore, and D. Waller. 1975. Neutral red with photoinactivation in the treatment of herpes genitalis. Br. J. Vener. Dis. 51:130-133.
34. Sharman, W. M., C. M. Allen, and J. E. van Lier. 1999. Photodynamic therapeutics: basic principles and clinical applications. Drug Discov. Today 4:507-517.
35. Shikowitz, M. J., A. L. Abramson, K. Freeman, B. M. Steinberg, and M. Nouri. 1998. Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results. Laryngoscope 108:962-967.
36. Shikowitz, M. J., A. L. Abramson, B. M. Steinberg, J. DeVoti, V. R. Bonagura, V. Mullooly, M. Nouri, A. M. Ronn, A. Inglis, J. McClay, and K. Freeman. 2005. Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis. Arch. Otolaryngol. Head Neck Surg. 131:99-105.
37. Tang, W., H. Xu, R. Kopelman, and M. A. Philbert. 2005. Photodynamic characterization and in vitro application of methylene blue-containing nanoparticle platforms. Photochem. Photobiol. 81:242-249.
38. Tang, W., H. Xu, E. J. Park, M. A. Philbert, and R. Kopelman. 2008. Encapsulation of methylene blue in polyacrylamide nanoparticle platforms protects its photodynamic effectiveness. Biochem. Biophys. Res. Commun. 369:579-583.
39. Teichert, M. C., J. W. Jones, M. N. Usacheva, and M. A. Biel. 2002. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 93:155-160.
40. Tuite, E. M., and J. M. Kelly. 1993. Photochemical interactions of methylene blue and analogues with DNA and other biological substrates. J. Photochem. Photobiol. B 21:103-124.
41. Usacheva, M. N., M. C. Teichert, and M. A. Biel. 2001. Comparison of the methylene blue and toluidine blue photobactericidal efficacy against gram-positive and gram-negative microorganisms. Lasers Surg. Med. 29:165-173.
42. Usacheva, M. N., M. C. Teichert, and M. A. Biel. 2003. The role of the methylene blue and toluidine blue monomers and dimers in the photoinactivation of bacteria. J. Photochem. Photobiol. B 71:87-98.
43. Wainwright, M. 1996. Non-porphyrin photosensitizers in biomedicine. Chem. Soc. Rev. 25:351-359.
44. Wainwright, M. 1998. Photodynamic antimicrobial chemotherapy (PACT). J. Antimicrob. Chemother. 42:13-28.
45. Wainwright, M., D. A. Phoenix, S. L. Laycock, D. R. Wareing, and P. A. Wright. 1998. Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol. Lett. 160:177-181.
46. Wainwright, M., D. A. Phoenix, L. Rice, S. M. Burrow, and J. Waring. 1997. Increased cytotoxicity and phototoxicity in the methylene blue series via chromophore methylation. J. Photochem. Photobiol. B 40:233-239.
47. Williams, J. L., J. Stamp, R. Devonshire, and G. J. Fowler. 1989. Methylene blue and the photodynamic therapy of superficial bladder cancer. J. Photochem. Photobiol. B 4:229-232.
48. Wood, S., D. Metcalf, D. Devine, and C. Robinson. 2006. Erythrosine is a potential photosensitizer for the photodynamic therapy of oral plaque biofilms. J. Antimicrob. Chemother. 57:680-684.
49. Wood, S., B. Nattress, J. Kirkham, R. Shore, S. Brookes, J. Griffiths, and C. Robinson. 1999. An in vitro study of the use of photodynamic therapy for the treatment of natural oral plaque biofilms formed in vivo. J. Photochem. Photobiol. B 50:1-7.
50. Xi, C., D. Marks, S. Schlachter, W. Luo, and S. A. Boppart. 2006. High-resolution three-dimensional imaging of biofilm development using optical coherence tomography. J. Biomed. Opt. 11:34001.
51. Xu, H., S. M. Buck, R. Kopelman, M. A. Philbert, M. Brasuel, B. D. Ross, and A. Rehemtulla. 2004. Photoexcitation-based nano-explorers: chemical analysis inside live cells and photodynamic therapy. Israel J. Chem. 44:317-337.
52. Zolfaghari, P. S., S. Packer, M. Singer, S. P. Nair, J. Bennett, C. Street, and M. Wilson. 2009. In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent. BMC Microbiol. 9:27.